1. Home
  2. GRFS vs IBP Comparison

GRFS vs IBP Comparison

Compare GRFS & IBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • IBP
  • Stock Information
  • Founded
  • GRFS 1940
  • IBP 1977
  • Country
  • GRFS Spain
  • IBP United States
  • Employees
  • GRFS N/A
  • IBP N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • IBP Homebuilding
  • Sector
  • GRFS Health Care
  • IBP Consumer Discretionary
  • Exchange
  • GRFS Nasdaq
  • IBP Nasdaq
  • Market Cap
  • GRFS 7.2B
  • IBP 7.4B
  • IPO Year
  • GRFS 2006
  • IBP 2014
  • Fundamental
  • Price
  • GRFS $9.87
  • IBP $261.00
  • Analyst Decision
  • GRFS Hold
  • IBP Hold
  • Analyst Count
  • GRFS 1
  • IBP 10
  • Target Price
  • GRFS $10.30
  • IBP $220.88
  • AVG Volume (30 Days)
  • GRFS 489.5K
  • IBP 440.4K
  • Earning Date
  • GRFS 01-01-0001
  • IBP 11-06-2025
  • Dividend Yield
  • GRFS 1.47%
  • IBP 1.23%
  • EPS Growth
  • GRFS 132.60
  • IBP 0.34
  • EPS
  • GRFS 0.53
  • IBP 8.99
  • Revenue
  • GRFS $8,744,226,659.00
  • IBP $2,955,900,000.00
  • Revenue This Year
  • GRFS $6.00
  • IBP $0.30
  • Revenue Next Year
  • GRFS $6.71
  • IBP $2.03
  • P/E Ratio
  • GRFS $24.37
  • IBP $28.86
  • Revenue Growth
  • GRFS 9.32
  • IBP 3.44
  • 52 Week Low
  • GRFS $6.19
  • IBP $150.83
  • 52 Week High
  • GRFS $11.14
  • IBP $280.00
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 47.26
  • IBP 51.88
  • Support Level
  • GRFS $9.63
  • IBP N/A
  • Resistance Level
  • GRFS $10.14
  • IBP $274.77
  • Average True Range (ATR)
  • GRFS 0.18
  • IBP 7.70
  • MACD
  • GRFS -0.02
  • IBP -12.81
  • Stochastic Oscillator
  • GRFS 46.15
  • IBP 93.21

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About IBP Installed Building Products Inc.

Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.

Share on Social Networks: